XML 105 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Notes)
12 Months Ended
Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Share-Based Compensation
Share-based compensation expense is included in ‘compensation and benefits’ in the consolidated income statements and totaled $9.3 million, $5.9 million and $2.3 million for the fiscal years ended 2013, 2012 and 2011, respectively.
Stock Option Plans
The Company sponsors a stock option plan for its directors, officers, employees and consultants. The Company’s Board of Directors approved a new stock option plan (“the 2013 Stock Option Plan”), which was approved by the Company’s shareholders at the 2013 annual meeting, and authorized the Company to issue stock options covering up to 1.0 million shares of the Company’s common stock. As of September 30, 2013, there were 1.0 million shares authorized for future grant under this plan. Awards that expire or are canceled generally become available for issuance again under the plan. The Company settles stock option exercises with newly issued shares of common stock.
Fair value is estimated at the grant date based on a Black-Scholes-Merton option-pricing model using the following weighted-average assumptions:
 
Year Ended September 30,
 
2013
 
2012
 
2011
Expected stock price volatility
35
%
 
57
%
 
77
%
Expected dividend yield
%
 
%
 
%
Risk free interest rate
0.37
%
 
1.53
%
 
0.72
%
Average expected life (in years)
2.88

 
7.86

 
2.94


Expected stock price volatility rates are primarily based on the historical volatility. The Company has not paid dividends in the past and does not currently expect to do so in the future. Risk free interest rates are based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option or award. The average expected life represents the estimated period of time that options or awards granted are expected to be outstanding, based on the Company’s historical share option exercise experience for similar option grants. The weighted average fair value of options issued during fiscal years ended 2013, 2012 and 2011 was $4.21, $13.57 and $11.66, respectively.
The following is a summary of stock option activity for the year ended September 30, 2013:
 
Shares
Available for
Grant
 
Number of
Options
Outstanding
 
Weighted
Average 
Exercise Price
 
Weighted
Average
Grant Date
Fair Value
 
Weighted
Average
Remaining
Term
(in years)
 
Aggregate
Intrinsic
Value
($ millions)
Balances at September 30, 2012
921,412

 
1,890,634

 
$
23.36

 
$
11.11

 
5.45
 
$
6.0

Additional shares authorized by shareholders
1,000,000

 
 
 
 
 
 
 
 
 
 
Termination of 2003 plan
(821,412
)
 
 
 
 
 
 
 
 
 
 
Granted
(100,000
)
 
100,000

 
$
17.53

 
$
4.21

 
 
 
 
Exercised
 
 
(177,246
)
 
$
8.40

 
$
5.26

 
 
 
 
Forfeited

 
(32,738
)
 
$
10.35

 
$
3.88

 
 
 
 
Expired

 
(667
)
 
$
23.49

 
$
11.58

 
 
 
 
Balances at September 30, 2013
1,000,000

 
1,779,983

 
$
24.76

 
$
11.44

 
4.87
 
$
4.8

Exercisable at September 30, 2013
 
 
680,820

 
$
27.47

 
$
11.04

 
1.91
 
$
3.1


The total compensation cost not yet recognized for non-vested awards of $10.0 million as of September 30, 2013 has a weighted-average period of 5.71 years over which the compensation expense is expected to be recognized. The total intrinsic value of options exercised during fiscal years 2013, 2012 and 2011 was $2.0 million, $3.0 million and $1.6 million, respectively.
The options outstanding as of September 30, 2013 broken down by exercise price are as follows:
Exercise Price
 
Number of Options Outstanding
 
Weighted Average Exercise Price
 
Weighted Average Remaining Term
(in Years)
$

-
$
5.00

 

 

n/a

 
n/a
$
5.00

-
$
10.00

 
301,875

 
$
7.02

 
1.18
$
10.00

-
$
15.00

 

 

n/a

 
n/a
$
15.00

-
$
20.00

 
322,179

 
$
18.01

 
2.40
$
20.00

-
$
25.00

 
126,204

 
$
23.52

 
3.10
$
25.00

-
$
30.00

 
800,000

 
$
25.91

 
8.22
$
30.00

-
$
35.00

 

 

n/a

 
n/a
$
35.00

-
$
40.00

 

 

n/a

 
n/a
$
40.00

-
$
45.00

 

 

n/a

 
n/a
$
45.00

-
$
50.00

 

 

n/a

 
n/a
$
50.00

-
$
55.00

 
229,725

 
$
54.23

 
2.45
 
 
 
 
1,779,983

 
$
24.76

 
4.87

Restricted Stock Plan
The Company sponsors a restricted stock plan for its directors, officers and employees. On January 31, 2012, the Company’s 2007 restricted stock plan expired. On February 23, 2012, shareholders approved the Company’s 2012 restricted stock plan authorizing up to 1.5 million shares to be issued. As of September 30, 2013, 1,154,862 shares were authorized for future grant under the restricted stock plan. Awards that expire or are canceled generally become available for issuance again under the plan. The Company utilizes newly issued shares of common stock to make restricted stock grants.
The following is a summary of restricted stock activity through September 30, 2013:
 
Shares
Available for
Grant
 
Number of
Shares
Outstanding
 
Weighted
Average
Grant Date
Fair Value
 
Weighted
Average
Remaining
Term
(in years)
 
Aggregate
Intrinsic Value
($ millions)
Balances at September 30, 2012
1,420,114

 
512,124

 
$
22.09

 
1.81
 
$
9.8

Granted
(268,885
)
 
268,885

 
$
17.92

 
 
 
 
Vested
 
 
(406,901
)
 
$
20.72

 
 
 
 
Forfeited
3,633

 
(10,470
)
 
$
22.62

 
 
 
 
Balances at September 30, 2013
1,154,862

 
363,638

 
$
20.53

 
1.74
 
$
7.4


The total compensation cost not yet recognized of $4.9 million as of September 30, 2013 has a weighted-average period of 1.74 years over which the compensation expense is expected to be recognized. Compensation expense is amortized on a straight-line basis over the vesting period. Restricted stock grants are included in the Company’s total issued and outstanding common shares.
The Company and an executive of a wholly owned subsidiary mutually agreed to the executive’s retirement from employment as of July 1, 2013. As a result of the executive’s retirement from employment, the Company recorded compensation cost, related to the individual’s restricted stock, of $2.6 million during the fiscal year ended September 30, 2013.